Diabetes

By Heather Mack July 26, 2016
San Francisco-based Omada Health, an online and mobile behavioral medicine company, announced today a partnership with the American Medical Association and a new customer, Utah-based Intermountain Healthcare system, which will offer Omada’s flagship diabetes prevention program (DPP), Prevent, to its patients. The Prevent program aims to reduce the number of adults who develop type 2 diabetes. All...
By Heather Mack July 22, 2016
An FDA advisory panel has voted in favor of recommending a change to the intended use of Dexcom’s G5 Continuous Glucose Monitor (CGM). The G5 had already been FDA-approved, but with limitations as an adjunctive device, meaning it could only be used for tracking and trending interstitial fluid gluocose concentrations rather than as a full replacement for a traditional fingerstick blood glucose...
By Jonah Comstock June 13, 2016
A number of pieces of interesting health tech news came out of the 76th Annual Scientific Sessions of the American Diabetes Association, held this weekend in New Orleans. Here’s a roundup of the highlights. Updated 6/15/2016 to include some more news items. IBM’s Medtronic partnership gets a name. Information has been trickling out about Medtronic’s collaboration with IBM Watson Health that was...
By Jonah Comstock May 25, 2016
Medtronic announced that it will work with Qualcomm Life to develop a new generation of smaller, affordable continuous glucose monitors (CGMs) for people with Type 2 diabetes, the companies announced today. Currently, CGM devices are mostly prescribed for people with Type 1 diabetes, while those with Type 2 are more likely to use discrete finger-prick glucometers. However, this new partnership...
By Jonah Comstock May 23, 2016
Los Angeles-based Canary Health, a startup that uses digital health tools to help populations prevent and manage chronic diseases, has acquired stress management app company bLife for an undisclosed amount.  Canary Health sells its disease-management programs to hospitals and health systems, whereas bLife was a direct-to-consumer app company that created direct-to-consumer stress management apps...
By Jonah Comstock April 13, 2016
As their famous rallying cry states, the patients behind the Nightscout project for creating a do-it-yourself mobile technology for diabetes management are not waiting for approval from the FDA. But that doesn't mean they aren't seeking it, or that they haven't been in contact with the regulatory organization to make sure Nightscout is as safe as it can be. In a new editorial published in the...
By Jonah Comstock March 23, 2016
WebMD partnered with Verizon to offer digital health coaching to 1,100 of Verizon's employees in a recent pilot, Employee Benefit News reports. The program led to weight loss for 73 percent of participants. Verizon employees were invited to participate after taking a health assessment if they had a BMI over 30 or a blood glucose level above a certain threshold. The program included one-on-one...
By Jonah Comstock March 22, 2016
Researchers from Massachusetts flexible electronics company MC10 and from Seoul National University in South Korea have created a prototype skin patch that could both monitor blood glucose levels and administer drugs like insulin or Metformin to patients with diabetes. In the study, recently published in Nature Nanotechnology, researchers used a combination of graphene and gold mesh to create the...
By Jonah Comstock February 8, 2016
A small study published in Diabetes Care, the journal of the American Diabetes Association, shows that personalized text messages with positive and negative feedback are more effective than texts that are simply reminders. The study was conducted by researchers at the Israeli Institute of Technology and one researcher was affiliated with Microsoft Research. They split 27 patients into a seven-...
By Jonah Comstock February 4, 2016
Germantown, Maryland-based Senseonics' Eversense continuous glucose monitor, which promises to be less invasive and longer lasting than traditional CGMs, still isn’t FDA cleared or CE-marked. But the company, which filed for an IPO last month, is pushing ahead on a partnership to maximize the user experience of its device, and to establish a pipeline for sending its data to users’ healthcare...